Trial Profile
Saxagliptin upregulates nesfatin-1 secretion in type 2 diabetes mellitus: a 52-week controlled trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2017
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 14 Jul 2017 New trial record